South Korean researchers developed a technology dubbed ‘contactless mobile pig weight manager’ that can 3D-scan a livestock pig to measure its weight.
The new technology makes use of a specialized algorithm to calculate the pig’s weight in less than 10 seconds, 60 times faster than traditional methods, with more than 95 percent accuracy.
ICT startup Illuvation has developed the said technology, according to the Institute of Planning and Evaluation for Technology in Food, Agriculture, and Forestry, which sponsored the startup.
According to Illuvation, the new weight manager has increased the chance of identifying grade 1 pigs by around 14 percentage points than previous methods.
Making weight-measuring quick and efficient will expedite the pig’s shipping process, which will save up to 10 percent and 4 percent of the pig farm’s annual feeding and management cost.


CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Japan's Business Confidence Rises Despite Iran War Uncertainty, BOJ Rate Hike Expected
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
Bank of America's $72.5M Epstein Settlement: What You Need to Know
U.S. Stock Futures Surge After WSJ Report on Trump's Iran War Exit Strategy
Goldman Sachs Sees Value in European Real Estate Stocks Despite Sharp Selloff
Oil Prices Dip as Trump Eyes Iran De-escalation, Hormuz Closure Persists
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
South Korea's $17.3 Billion Emergency Budget Targets Oil Price Surge
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
Tabletop particle accelerator could transform medicine and materials science
Asian Currencies Hold Steady Amid U.S.-Israel-Iran Tensions and BOJ Signals
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment 



